TY - JOUR
T1 - Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11
AU - Undiagnosed Diseases Network
AU - Ravenscroft, Thomas A.
AU - Phillips, Jennifer B.
AU - Fieg, Elizabeth
AU - Bajikar, Sameer S.
AU - Peirce, Judy
AU - Wegner, Jeremy
AU - Luna, Alia A.
AU - Fox, Eric J.
AU - Yan, Yi Lin
AU - Rosenfeld, Jill A.
AU - Zirin, Jonathan
AU - Kanca, Oguz
AU - Acosta, Maria T.
AU - Adam, Margaret
AU - Adams, David R.
AU - Agrawal, Pankaj B.
AU - Alejandro, Mercedes E.
AU - Alvey, Justin
AU - Amendola, Laura
AU - Andrews, Ashley
AU - Ashley, Euan A.
AU - Azamian, Mahshid S.
AU - Bacino, Carlos A.
AU - Bademci, Guney
AU - Baker, Eva
AU - Balasubramanya, Ashok
AU - Baldridge, Dustin
AU - Bale, Jim
AU - Bamshad, Michael
AU - Barbouth, Deborah
AU - Bayrak-Toydemir, Pinar
AU - Beck, Anita
AU - Beggs, Alan H.
AU - Behrens, Edward
AU - Bejerano, Gill
AU - Bennet, Jimmy
AU - Berg-Rood, Beverly
AU - Bernstein, Jonathan A.
AU - Berry, Gerard T.
AU - Bican, Anna
AU - Bivona, Stephanie
AU - Blue, Elizabeth
AU - Bohnsack, John
AU - Bonnenmann, Carsten
AU - Cole, F. Sessions
AU - Pak, Stephen
AU - Schedl, Timothy
AU - Shin, Jimann
AU - Solnica-Krezel, Lilianna
AU - Wambach, Jennifer
N1 - Funding Information:
We thank the patients and their families who participated in this study. The research reported in this paper was supported by the National Institutes of Health (NIH_ Common Fund, the Office of Strategic Coordination and Office of the NIH Director under award numbers U01HG007942 (BCM sequencing core), U54NS093793 (Model Organism Screening Center of the Undiagnosed Diseases Network), R24OD026591 (J.H.P and M.W), and U01HG007690 (BWH clinical site). The Care4Rare Research Consortium performed the reanalysis of the exome data for patient 5 and is funded by Genome Canada and the Ontario Genomics Institute (OGI-147), the Canadian Institutes of Health Research, Ontario Research Fund, Genome Alberta, Genome British Columbia, Genome Q8 Quebec, and Children’s Hospital of Eastern Ontario Foundation. H.J.B. and S.Y. are supported by R24OD022005 from the Office of Research Infrastructure Programs (ORIP) at NIH. myo-T2A-GAL4 generation was funded as part of the genome disruption project (NIGMS GM132087). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. T.A.R. has been supported by The Cullen Foundation. S.S.B. is supported by F32HD100048 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at NIH. H.J.B. is an investigator of the Howard Hughes Medical Institute.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics.
PY - 2021/10
Y1 - 2021/10
N2 - Purpose: Growth differentiation factor 11 (GDF11) is a key signaling protein required for proper development of many organ systems. Only one prior study has associated an inherited GDF11 variant with a dominant human disease in a family with variable craniofacial and vertebral abnormalities. Here, we expand the phenotypic spectrum associated with GDF11 variants and document the nature of the variants. Methods: We present a cohort of six probands with de novo and inherited nonsense/frameshift (4/6 patients) and missense (2/6) variants in GDF11. We generated gdf11 mutant zebrafish to model loss of gdf11 phenotypes and used an overexpression screen in Drosophila to test variant functionality. Results: Patients with variants in GDF11 presented with craniofacial (5/6), vertebral (5/6), neurological (6/6), visual (4/6), cardiac (3/6), auditory (3/6), and connective tissue abnormalities (3/6). gdf11 mutant zebrafish show craniofacial abnormalities and body segmentation defects that match some patient phenotypes. Expression of the patients’ variants in the fly showed that one nonsense variant in GDF11 is a severe loss-of-function (LOF) allele whereas the missense variants in our cohort are partial LOF variants. Conclusion: GDF11 is needed for human development, particularly neuronal development, and LOF GDF11 alleles can affect the development of numerous organs and tissues.
AB - Purpose: Growth differentiation factor 11 (GDF11) is a key signaling protein required for proper development of many organ systems. Only one prior study has associated an inherited GDF11 variant with a dominant human disease in a family with variable craniofacial and vertebral abnormalities. Here, we expand the phenotypic spectrum associated with GDF11 variants and document the nature of the variants. Methods: We present a cohort of six probands with de novo and inherited nonsense/frameshift (4/6 patients) and missense (2/6) variants in GDF11. We generated gdf11 mutant zebrafish to model loss of gdf11 phenotypes and used an overexpression screen in Drosophila to test variant functionality. Results: Patients with variants in GDF11 presented with craniofacial (5/6), vertebral (5/6), neurological (6/6), visual (4/6), cardiac (3/6), auditory (3/6), and connective tissue abnormalities (3/6). gdf11 mutant zebrafish show craniofacial abnormalities and body segmentation defects that match some patient phenotypes. Expression of the patients’ variants in the fly showed that one nonsense variant in GDF11 is a severe loss-of-function (LOF) allele whereas the missense variants in our cohort are partial LOF variants. Conclusion: GDF11 is needed for human development, particularly neuronal development, and LOF GDF11 alleles can affect the development of numerous organs and tissues.
UR - http://www.scopus.com/inward/record.url?scp=85107767922&partnerID=8YFLogxK
U2 - 10.1038/s41436-021-01216-8
DO - 10.1038/s41436-021-01216-8
M3 - Article
C2 - 34113007
AN - SCOPUS:85107767922
SN - 1098-3600
VL - 23
SP - 1889
EP - 1900
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 10
ER -